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Abstract Helicobacter pylori, one of the most
frequently observed bacterium in the human intestinal
flora, has been widely studied since Marshall and
Warren documented a link between the presence of H.
pylori in the gastrointestinal tract and gastritis and
gastric ulcers. Interestingly, H. pylori has also been
found in several other epithelial tissues, including the
eyes, ears, nose and skin that may have direct or
indirect effects on host physiology and may contribute
to extragastric diseases, e.g. chronic skin diseases.
More recently, it has been shown that H. pylori
cytotoxin CagA expression induces cellular senes-
cence of human gastric nonpolarized epithelial cells
that may lead to gastrointestinal disorders and sys-
temic inflammation. Here, we hypothesize that also
chronic skin diseases may be promoted by stress-
induced premature senescence (SIPS) of skin cells,
namely fibroblasts and keratinocytes, stimulated with
H. pylori cytotoxins. Future studies involving cell
culture models and clinical specimens are needed to
verify the involvement of H. pylori in SIPS-based
chronic skin diseases.
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What are the causes of chronic skin diseases?
Despite the fact that chronic skin diseases, such as
erythema, psoriasis, Henoch-Scho¨nlein purpura,
alopecia areata, Sweet disease, chronic urticaria,
systemic sclerosis, Behcet disease, generalized pruri-
tus (itch), nodular prurigo, lichen planus, aphthous
ulceration, Sjo¨gren syndrome and atopic dermatitis,
are frequently diagnosed and comprehensively stud-
ied, they are still considered as troublesome human
diseases of a complex etiopathogenesis (Hernando-
Harder et al. 2009; Mogaddam et al. 2015; Wedi and
Kapp 2002). It is speculated that approximately ten
percent of worldwide population is affected by atopic
dermatitis (AD) (Weidinger and Novak 2016). The
causes of AD remain elusive. AD is considered a
genetic-based immunological disorder associated with
the hypersensitivity of the immune system and aber-
rant response to antigens (allergens). The questions on
hereditary patterns, haplotypes and allergens involved
in the pathogenesis of AD are left unanswered (Bieber
2010; Brown 2016; Wuthrich et al. 2007). Thus, there
is a need for alternative hypotheses on the mechanisms
underlying the initiation and progression of chronic
skin diseases/conditions. It seems reasonable to cor-
relate inflammatory skin disorders with stress-induced
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premature senescence (SIPS) in human skin cells
(Bellei et al. 2012) that is also accompanied by
senescence-associated secretory phenotype (SASP)
(Demaria et al. 2015; Ovadya and Krizhanovsky 2014;
Tchkonia et al. 2013) that is primarily a DNA damage
response (Rodier et al. 2009). Cellular senescence is a
natural mechanism to prevent oncogenic transforma-
tion of DNA-damaged somatic cells that is based on
permanent inhibition of cell proliferation and cell
cycle arrest (Campisi 2011). However, senescent cells
are metabolically active or even hyperactive and are
able to produce pro-inflammatory factors, namely
interleukins, chemokines and growth factors that may
have adverse effects on surrounding cells and tissues
(Demaria et al. 2015; Kennedy et al. 2014). There are
several stress stimuli that can promote/potentiate
SIPS, like chemicals (e.g. hydrogen peroxide) (Chen
et al. 1998), drugs (e.g. doxorubicin) (Bielak-Zmi-
jewska et al. 2014), nutraceuticals (e.g. curcumin)
(Grabowska et al. 2015), nanoparticles (Mytych et al.
2015) as well as bacterial toxins (e.g. pyocyanin or
lipopolysaccharide) (Kim et al. 2016; Muller 2006)
and viruses (e.g. papillomavirus) (Ren et al. 2013). In
this view, it would be essential to understand the
relationship between bacterial infection-mediated cel-
lular senescence and systemic diseases, especially in
terms of H. pylori-mediated SIPS (Saito et al. 2010),
SASP, gastric diseases and perhaps extragastric
diseases.
H. pylori infection and systematic diseases
H. pylori is a microaerophile, a Gram-negative
bacterium (bacillus of helical or curved shape) of
approximately 0.5–1 lm 9 2.5–5 lm (width 9 -
length). Due to the presence of diametrically located
flagella, H. pylori is able to move and colonize under
mucosa. In general, H. pylori is found in the stomach,
especially in the gastric mucosa and duodenum being
responsible for gastroduodenal diseases such as peptic
ulcer disease or gastric carcinoma (Marshall and
Warren 1984). Undoubtedly, H. pylori is one of the
most widespread pathogen among humans, especially
in the gastrointestinal tract, and human-H. pylori co-
existence is calculated to be approximately for
60,000 years (Linz et al. 2007; Moodley et al. 2012).
According to World Health Organization, it is spec-
ulated that approximately a half of the population of
developed countries and 80% of the population of
developing countries is affected by H. pylori infection
(Linz et al. 2007). Surprisingly, H. pylori is able to
tolerate a broad range of oxygen concentrations,
especially at liquid culture at high cell density, namely
it can grow at microaerophilic conditions (\5%) as
well as at aerobic conditions (21%) (Bury-Mone et al.
2006). H. pylori can also form biofilms as well as
transform from its normal helical bacillary morphol-
ogy to a coccoid morphology as a survival strategy and
expansion (Andersen and Rasmussen 2009; Cam-
marota et al. 2012; Stark et al. 1999). Unique
adaptation features of H. pylori are probably respon-
sible for occasional or persistent colonization of other
human tissues including skin (Testerman and Morris
2014).
Despite numerous studies on the mechanisms of H.
pylori transmission, data on H. pylori routes of
transmission are ambiguous. It is suggested that
human is a main disease carrier (reservoir of H.
pylori) and several transmission routes are considered,
namely gastro–oral, oral–oral and fecal–oral routes
(Brown 2000; Schwarz et al. 2008). Thus, saliva and
faeces may be considered important for H. pylori
transmission. The PCR analysis on 102 human saliva
samples revealed that 66 individuals were affected by
H. pylori (Wnuk et al. 2010). Of course, it should be
further examined if genetic material of H. pylori is
from live or dead bacteria, but the presence of live
bacterial cells in saliva has been also documented by
others (Li et al. 1996). Thus, the presence of H. pylori
in saliva may be important not only for the transmis-
sion of chronic infections of the gastrointestinal tract,
but also for the propagation of chronic skin diseases in
humans. So, one can ask a question if chronic skin
diseases are a result of the exposition to saliva and/or
faeces containing live or dead forms of H. pylori with
damaged/injured skin. During such second transmis-
sion, H. pylori may also colonize host skin tissues.
Moreover, dead cells of H. pylori may also promote
inflammation as a response to bacterial antigens
released from dead cells.H. pylori produces a plethora
of virulence factors, namely enzymes, endotoxins and
hemolysins that allows for survival at low pH in the
stomach, adhesion to host cells, re-programming of
host cell cytophysiology and attenuation of immune
responses (Backert et al. 2016). On the other hand, H.
pylori-based virulence factors are responsible for
chronic infections of the gastrointestinal tract,
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especially for chronic gastritis leading to gastric and
duodenal ulcers and gastric MALT (mucosa associ-
ated lymphoid tissue) lymphoma as a response to
prolonged stimulation of immune system (Testerman
and Morris 2014).
A potential role of H. pylori infection in several
extragastric diseases, namely hematological, cardio-
vascular, neurological, metabolic, autoimmune and
dermatological diseases, has been also proposed
(Hernando-Harder et al. 2009; Kutlubay et al. 2014;
Magen and Delgado 2014; Testerman and Morris
2014; Wedi and Kapp 2002). An association between
H. pylori infection and skin diseases such as chronic
idiopathic urticaria and rosacea has been suggested
(Kutlubay et al. 2014). For example, H. pylori
(cagA ? strains) was present in 81% of rosacea
patients who also had gastric complaints (Argenziano
et al. 2003). Eradication ofH. pylori infection has been
reported to be effective in some patients with chronic
autoimmune urticaria, psoriasis, alopecia areata and
Henoch-Scho¨nlein purpura (Magen and Delgado
2014). H. pylori may be considered as a plausible
infectious agent for triggering autoimmunity (Magen
and Delgado 2014). Cytotoxins produced by H. pylori
may activate cross-reactive T cells and stimulate the
production of autoantibodies (Magen and Delgado
2014). Moreover, H. pylori heat shock proteins (HSP)
with sequence similarity to human HSP may play a
role in the pathogenesis of autoimmune diseases
(Magen and Delgado 2014). However, the role of H.
pylori in the pathogenesis of some dermatological
diseases has been also questioned (Kutlubay et al.
2014; Magen and Delgado 2014). Patients with mild to
severe psoriasis were not found to be more susceptible
to H. pylori infection; however, H. pylori affected the
clinical severity of psoriasis (Campanati et al. 2015).
H. pylori eradication was reported to have no
discernible effect on chronic spontaneous urticaria
(CSU) beyond that of standard CSU therapy (Curth
et al. 2015). Thus, more epidemiological and clinical
studies are needed to investigate the association
between H. pylori and inflammatory skin diseases.
H. pylori proteins may be considered as drivers
of cellular senescence
H. pylori produces many proteins that are highly
immunogenic and are directly and/or indirectly
responsible for multiple pathogen-host interactions
during infection. Some of these proteins like antiox-
idative enzymes, neutrophil-activating protein (HP-
NAP) or other virulence factors, namely proteases,
lipases, cholesteryl glucosides, adhesins, iron trans-
porters, O-lipopolysaccharide may be helpful during
human skin invasion by H. pylori as well as respon-
sible for local inflammation (Bumann et al. 2002;
Testerman and Morris 2014; Zanotti and Cendron
2014). H. pylori secretome can be grouped into
different categories, one of them are products of the
cytotoxic-associated genes of pathogenicity island (8
proteins) and other toxins (5 proteins) (Zanotti and
Cendron 2014). Two secreted cytotoxins (oncopro-
teins), namely VacA and CagA are particularly
important for H. pylori-based pathologies.
Vacuolating cytotoxin A (VacA, 88 kDa protein)
inhibits the proliferation of epithelial cells, modifies
pathways involved in the cytoskeleton reorganization
and induces apoptosis by release of cytochrome c from
mitochondria. VacA is also able to inhibit the prolif-
eration of T lymphocytes and phagocytosis and
antigen presentation to T lymphocytes that in turn
results in the attenuation of immune responses. VacA
can also modify cell junctions between neighbouring
gastric epithelial cells (Gebert et al. 2003; Palframan
et al. 2012).
Cytotoxin associated protein A (CagA,
120–145 kDa protein) is encoded by cagA gene within
the cag pathogenicity island (cag PAI). CagA gene is
presented within 60% of genomes ofH. pylori isolated
from patients (Hatakeyama and Higashi 2005). Cyto-
toxin CagA is transported to epithelial cells by one-
step transport system T4SS from cytosol of bacterial
cell to host cell excluding periplasmic space. CagA
interacts with host cellular proteins involved in
signaling pathways regulating cell proliferation,
motility and polarity that modulates the phenotype
of host cells (Tohidpour 2016). CagA may promote
loss of polarity and activate aberrant ERK signaling in
host cells (Saito et al. 2010). In nonpolarized gastric
epithelial cells, CagA-induced ERK activation
resulted in oncogenic stress, upregulation of the
p21Waf1/Cip1 cyclin-dependent kinase inhibitor and
induction of senescence (Saito et al. 2010). In contrast,
in polarized epithelial cells, CagA-mediated ERK
signaling suppressed p21Waf1/Cip1 expression by acti-
vating a guanine nucleotide exchange factor–H1–
RhoA–RhoA-associated kinase–c-Myc pathway and
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c-Myc-mediated upregulation of miR-17 and miR-20a
that stimulated mitogenesis (Saito et al. 2010). Thus,
CagA may directly induce cellular senescence in host
cells, here gastric cells (Saito et al. 2010), that may be
important for the etiopathogenesis of gastric ulcer and
perhaps during initiation of chronic skin diseases
associated with the induction of secretory phenotype
in senescent skin cells.
Gastric and extragastric diseases associated
with H. pylori may have a common SIPS-based
molecular mechanism
We have already mentioned that H. pylori cytotoxin
CagA has been reported to stimulate cellular senes-
cence in nonpolarized gastric epithelial cells (Saito
et al. 2010).H. pylori L-asparaginase also inhibited the
cell cycle of normal human diploid fibroblasts (Scotti
et al. 2010). Of course, the question if such cell cycle
arrest would be permanent and lead to cellular
senescence needs to be addressed. In our opinion,
gastrointestinal disorders and chronic skin diseases
may have a common molecular basis that may be
mediated by stress-induced premature senescence. We
propose a hypothesis that H. pylori may promote
stress-induced premature senescence in skin cells that
in turn may lead to chronic inflammation and chronic
skin diseases (Fig. 1).
Although, there are no direct evidences that H.
pylorimay induce SIPS in skin cells, one can speculate
that such scenario is possible. First of all,H. pylori has
been found in different human tissues including skin
(Missall et al. 2012; Testerman and Morris 2014), as
well as in saliva and faeces (Brown 2000). Moreover,
H. pylori is able to tolerate a broad range of oxygen
concentrations (Bury-Mone et al. 2006) and H. pylori
possesses a plethora of enzyme activities that enables
for survival at low pH in the stomach that may be also
important during H. pylori-based skin infection, e.g.
urease that converts urea to ammonium and carbon
dioxide leading to local alkalization of acid pH in the
stomach (Bury-Mone et al. 2001; Cornally et al. 2008;
Tuzun et al. 2010). Thus, H. pylori is able to survive
outside the gastrointestinal tract and its presence in
other human tissues may affect host physiology and
potentially provoke extragastric disorders. Moreover,
the presence of H. pylori may promote redox imbal-
ance (increased production of reactive oxygen species
and reactive nitrogen species) (Handa et al. 2010) and
Fig. 1 Molecular details of proposed hypothesis on H. pylori-
mediated stress-induced premature senescence in skin cells and
chronic skin diseases. Future studies are needed to verify the
involvement of H. pylori and molecular players during SIPS-
based chronic skin diseases
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DNA damage (Hanada et al. 2014; Koeppel et al.
2015; Toller et al. 2011), inflammation and epigenetic
changes (Valenzuela et al. 2015) in host cells, all of
which are triggers and/or biomarkers of cellular
senescence.
In conclusion, it is postulated that the presence of
H. pylori in the stomach may also affect other human
tissues including skin and promote indirectly patho-
physiological conditions outside the gastrointestinal
tract (Magen and Delgado 2014; Testerman and
Morris 2014). Therefore, more studies are still needed
to verify our current knowledge on H. pylori as a
systemic infectious factor and human skin cell
responses to the presence of H. pylori as a part of
complex host-pathogen interactions, especially H. py-
lori-induced premature senescence in skin cells,
chronic inflammation and chronic skin diseases.
Future studies might involve skin cell line models as
well as clinical specimens and co-culture approach
using intact H. pylori cells and isolated cytotoxins.
Several biomarkers of cellular senescence could be
then analyzed (Fig. 1). The presence of H. pylori in
clinical skin samples could be also studied in an
association with some biomarkers of cellular senes-
cence in vivo.
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